COMP <GO>
UHS vs UNH // PIOTROSKI F-SCORE QUALITY
Universal Health Services Inc. (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: UHS 10
— UNH 3
▲ PIOTROSKI F-SCORE QUALITY LEADER: UHS
LAST: $180.65 (+2.61%) • MKT CAP: $10.65B
piotroski-score
9/9
LAST: $400.44 (-1.60%) • MKT CAP: $359.43B
piotroski-score
7/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (UHS VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | UHS | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 88.31% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 14.10% | 12.38% | +1.72 | UHS | /roic <GO> |
| EV/EBITDA & P/E Valuation | 5.0x | 15.3x | -10.27 | UHS | /valuation <GO> |
| Free Cash Flow Yield | 8.16% | 6.25% | +1.91 | UHS | /fcf-yield <GO> |
| Operating Margin | 11.50% | 5.32% | +6.18 | UHS | /operating-margins <GO> |
| Net Profit Margin | 8.60% | 3.53% | +5.07 | UHS | /net-margins <GO> |
| Revenue Growth (YoY) | 9.70% | 3.33% | +6.37 | UHS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.49% | 2.29% | -1.80 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.11 | 3.09 | +0.02 | UHS | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 9/9 | 7/9 | +2.00 | UHS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 7.00% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.8 | 55.1 | -2.30 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.04 | 0.33 | +0.71 | UHS | /macro-sensitivity <GO> |
| Forward P/E Multiple | 6.5x | 17.7x | -11.24 | UHS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.65B | $359.43B | -$348.79B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | UHS REV | UNH REV | UHS GROSS % | UNH GROSS % | UHS FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $17.36B | $447.57B | — | 88.7% | $849.2M | $16.07B |
| FY 2024 | $15.83B | $400.28B | — | 88.3% | $1.12B | $20.70B |
| FY 2023 | $14.28B | $371.62B | — | 89.6% | $625.1M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
UHS // BETA 1.04
UNH // BETA 0.33